Several pharmaceutical stocks have come under pressure recently, mainly due to concerns surrounding the proposed "Most Favored Nations" (MFN) pricing model. While the HHS announcement appeared sweeping in scope - targeting all branded drugs - we believe any meaningful impact on drug prices is unlikely Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opini ...